世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

2022-2026年の世界のCovid-19 ワクチン市場


Global Covid-19 Vaccination Market 2022-2026

コビド-19ワクチン接種の世界市場 2022-2026年 Technavio社は、covid-19ワクチン接種市場を監視しており、予測期間中に(36.56)%のCAGRで進行し、2022年から2026年の間に683.5億ドルの成長が見込まれています... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2021年10月27日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

コビド-19ワクチン接種の世界市場 2022-2026年
Technavio社は、covid-19ワクチン接種市場を監視しており、予測期間中に(36.56)%のCAGRで進行し、2022年から2026年の間に683.5億ドルの成長が見込まれています。当レポートでは、covid-19ワクチン接種市場について、全体的な分析、市場規模と予測、動向、成長要因、課題のほか、約25社のベンダーを対象としたベンダー分析も行っています。
本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、COVID-19感染症の発生率の増加と政府の有利な取り組みです。さらに、COVID-19感染症の発生率の増加は、市場の成長も後押しすると予想されています。
covid-19ワクチン市場の分析には、アプリケーションセグメントと地域別の状況が含まれています。
TechnavioのCOVID-19予防接種市場は以下のように区分されています。
アプリケーション別
- mRNA
- その他
地理的状況別
- 北アメリカ
- アジア
- ヨーロッパ
- ROW
本調査では、効率的な予防接種に対する意識の高まりが、今後数年間のCOVID-19予防接種市場の成長を促す主要な理由の一つであるとしています。
Technavio社は、複数の情報源から得たデータを調査、合成、主要パラメータの分析によってまとめ、市場の詳細な状況を提示しています。当レポートでは、COVID-19ワクチン接種市場について、以下の項目を取り上げています。
- COVID-19ワクチン接種市場のサイジング
- COVID-19ワクチン接種市場の予測
- COVID-19ワクチン接種市場の産業分析
Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としており、本レポートではこれに沿って、AstraZeneca Plc、Bharat Biotech Ltd.、China National Pharmaceutical Group Corp.、Gamaleya National Center、Inovio Pharmaceuticals Inc.、Johnson and Johnson Inc.、Moderna Inc.、Novavax Inc.、Pfizer Inc.、Sinovac Biotech Ltd.など、COVID-19ワクチン接種市場の主要ベンダー数社の詳細な分析を行っています。また、COVID-19ワクチンの市場分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべきすべての成長機会を活用するためのものです。
本調査は、業界の主要参加者からの情報を含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/covid-19-vaccination-market-industry-analysis をご覧ください。
Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的・量的調査を用いた綿密なベンダー選択方法と分析を提供しています。

ページTOPに戻る


目次

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o mRNA - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AstraZeneca Plc
o Bharat Biotech Ltd.
o China National Pharmaceutical Group Corp.
o Gamaleya National Center
o Inovio Pharmaceuticals Inc.
o Johnson and Johnson Inc.
o Moderna Inc.
o Novavax Inc.
o Pfizer Inc.
o Sinovac Biotech Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: mRNA - Market size and forecast 2021-2026 ($ million)
• 24: mRNA - Year-over-year growth 2021-2026 (%)
• 25: Others - Market size and forecast 2021-2026 ($ million)
• 26: Others - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Application
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2021-2026 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2021-2026 ($ million)
• 32: North America - Year-over-year growth 2021-2026 (%)
• 33: Asia - Market size and forecast 2021-2026 ($ million)
• 34: Asia - Year-over-year growth 2021-2026 (%)
• 35: Europe - Market size and forecast 2021-2026 ($ million)
• 36: Europe - Year-over-year growth 2021-2026 (%)
• 37: ROW - Market size and forecast 2021-2026 ($ million)
• 38: ROW - Year-over-year growth 2021-2026 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: AstraZeneca Plc - Overview
• 48: AstraZeneca Plc - Product and service
• 49: AstraZeneca Plc - Key offerings
• 50: AstraZeneca Plc - Key customers
• 51: AstraZeneca Plc - Segment focus
• 52: Bharat Biotech Ltd. - Overview
• 53: Bharat Biotech Ltd. - Product and service
• 54: Bharat Biotech Ltd. - Key offerings
• 55: Bharat Biotech Ltd. - Key customers
• 56: Bharat Biotech Ltd. - Segment focus
• 57: China National Pharmaceutical Group Corp. - Overview
• 58: China National Pharmaceutical Group Corp. - Product and service
• 59: China National Pharmaceutical Group Corp. - Key offerings
• 60: China National Pharmaceutical Group Corp. - Key customers
• 61: China National Pharmaceutical Group Corp. - Segment focus
• 62: Gamaleya National Center - Overview
• 63: Gamaleya National Center - Product and service
• 64: Gamaleya National Center - Key offerings
• 65: Gamaleya National Center - Key customers
• 66: Gamaleya National Center - Segment focus
• 67: Inovio Pharmaceuticals Inc. - Overview
• 68: Inovio Pharmaceuticals Inc. - Product and service
• 69: Inovio Pharmaceuticals Inc. - Key offerings
• 70: Inovio Pharmaceuticals Inc. - Key customers
• 71: Inovio Pharmaceuticals Inc. - Segment focus
• 72: Johnson and Johnson Inc. - Overview
• 73: Johnson and Johnson Inc. - Business segments
• 74: Johnson and Johnson Inc. - Key offerings
• 75: Johnson and Johnson Inc. - Key customers
• 76: Johnson and Johnson Inc. - Segment focus
• 77: Moderna Inc. - Overview
• 78: Moderna Inc. - Business segments
• 79: Moderna Inc. - Key offerings
• 80: Moderna Inc. - Key customers
• 81: Moderna Inc. - Segment focus
• 82: Novavax Inc. - Overview
• 83: Novavax Inc. - Business segments
• 84: Novavax Inc. - Key offerings
• 85: Novavax Inc. - Key customers
• 86: Novavax Inc. - Segment focus
• 87: Pfizer Inc. - Overview
• 88: Pfizer Inc. - Business segments
• 89: Pfizer Inc. - Key offerings
• 90: Pfizer Inc. - Key customers
• 91: Pfizer Inc. - Segment focus
• 92: Sinovac Biotech Ltd. - Overview
• 93: Sinovac Biotech Ltd. - Product and service
• 94: Sinovac Biotech Ltd. - Key offerings
• 95: Sinovac Biotech Ltd. - Key customers
• 96: Sinovac Biotech Ltd. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Covid-19 Vaccination Market 2022-2026
Technavio has been monitoring the covid-19 vaccination market and the growth is expected to reduce by $ 68.35 bn during 2022-2026, progressing at a CAGR of (36.56)% during the forecast period. Our report on the covid-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of COVID-19 infection and favorable government initiatives. In addition, the increasing incidence of COVID-19 infection is anticipated to boost the growth of the market as well.
The covid-19 vaccination market analysis includes the application segment and geographic landscape.
Technavio's covid-19 vaccination market is segmented as below:
By Application
• mRNA
• others
By Geographical Landscape
• North America
• Asia
• Europe
• ROW
This study identifies the rising awareness about efficient vaccinationas one of the prime reasons driving the COVID-19 vaccination market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on COVID-19 vaccination market covers the following areas:
• COVID-19 vaccination market sizing
• COVID-19 vaccination market forecast
• COVID-19 vaccination market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading COVID-19 vaccination market vendors that include AstraZeneca Plc, Bharat Biotech Ltd., China National Pharmaceutical Group Corp., Gamaleya National Center, Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Moderna Inc., Novavax Inc., Pfizer Inc., and Sinovac Biotech Ltd. Also, the COVID-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/covid-19-vaccination-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o mRNA - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AstraZeneca Plc
o Bharat Biotech Ltd.
o China National Pharmaceutical Group Corp.
o Gamaleya National Center
o Inovio Pharmaceuticals Inc.
o Johnson and Johnson Inc.
o Moderna Inc.
o Novavax Inc.
o Pfizer Inc.
o Sinovac Biotech Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: mRNA - Market size and forecast 2021-2026 ($ million)
• 24: mRNA - Year-over-year growth 2021-2026 (%)
• 25: Others - Market size and forecast 2021-2026 ($ million)
• 26: Others - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Application
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2021-2026 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2021-2026 ($ million)
• 32: North America - Year-over-year growth 2021-2026 (%)
• 33: Asia - Market size and forecast 2021-2026 ($ million)
• 34: Asia - Year-over-year growth 2021-2026 (%)
• 35: Europe - Market size and forecast 2021-2026 ($ million)
• 36: Europe - Year-over-year growth 2021-2026 (%)
• 37: ROW - Market size and forecast 2021-2026 ($ million)
• 38: ROW - Year-over-year growth 2021-2026 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: AstraZeneca Plc - Overview
• 48: AstraZeneca Plc - Product and service
• 49: AstraZeneca Plc - Key offerings
• 50: AstraZeneca Plc - Key customers
• 51: AstraZeneca Plc - Segment focus
• 52: Bharat Biotech Ltd. - Overview
• 53: Bharat Biotech Ltd. - Product and service
• 54: Bharat Biotech Ltd. - Key offerings
• 55: Bharat Biotech Ltd. - Key customers
• 56: Bharat Biotech Ltd. - Segment focus
• 57: China National Pharmaceutical Group Corp. - Overview
• 58: China National Pharmaceutical Group Corp. - Product and service
• 59: China National Pharmaceutical Group Corp. - Key offerings
• 60: China National Pharmaceutical Group Corp. - Key customers
• 61: China National Pharmaceutical Group Corp. - Segment focus
• 62: Gamaleya National Center - Overview
• 63: Gamaleya National Center - Product and service
• 64: Gamaleya National Center - Key offerings
• 65: Gamaleya National Center - Key customers
• 66: Gamaleya National Center - Segment focus
• 67: Inovio Pharmaceuticals Inc. - Overview
• 68: Inovio Pharmaceuticals Inc. - Product and service
• 69: Inovio Pharmaceuticals Inc. - Key offerings
• 70: Inovio Pharmaceuticals Inc. - Key customers
• 71: Inovio Pharmaceuticals Inc. - Segment focus
• 72: Johnson and Johnson Inc. - Overview
• 73: Johnson and Johnson Inc. - Business segments
• 74: Johnson and Johnson Inc. - Key offerings
• 75: Johnson and Johnson Inc. - Key customers
• 76: Johnson and Johnson Inc. - Segment focus
• 77: Moderna Inc. - Overview
• 78: Moderna Inc. - Business segments
• 79: Moderna Inc. - Key offerings
• 80: Moderna Inc. - Key customers
• 81: Moderna Inc. - Segment focus
• 82: Novavax Inc. - Overview
• 83: Novavax Inc. - Business segments
• 84: Novavax Inc. - Key offerings
• 85: Novavax Inc. - Key customers
• 86: Novavax Inc. - Segment focus
• 87: Pfizer Inc. - Overview
• 88: Pfizer Inc. - Business segments
• 89: Pfizer Inc. - Key offerings
• 90: Pfizer Inc. - Key customers
• 91: Pfizer Inc. - Segment focus
• 92: Sinovac Biotech Ltd. - Overview
• 93: Sinovac Biotech Ltd. - Product and service
• 94: Sinovac Biotech Ltd. - Key offerings
• 95: Sinovac Biotech Ltd. - Key customers
• 96: Sinovac Biotech Ltd. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/24 10:26

158.45 円

165.22 円

201.28 円

ページTOPに戻る